Red wine enhances glucose-dependent insulinotropic peptide (GIP) and insulin responses in type 2 diabetes during an oral glucose tolerance test.

Abstract

Ingestion of ethanol before a glucose challenge enhances the insulin response by an unknown mechanism. In addition, epidemiological studies consistently indicate that moderate alcohol consumption reduces the risk of developing type 2 diabetes (T2D). The purposes of this study were to evaluate the potential involvement of glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide 1 (GLP-1) in alcohol-induced augmentation of the insulin response and to determine if red wine acutely improves glucose tolerance during an oral glucose tolerance test (OGTT). Nine subjects (eight T2D and one pre-diabetes) completed two OGTT 30min after consumption of 263ml water or red wine (28g ethanol). Blood samples were obtained for 3h and analyzed for glucose, insulin, C-peptide, GIP, and GLP-1. Compared with water, consumption of red wine increased the incremental area under the curve (iAUC) for insulin by 50% (14,837±4759 vs. 9885±2686 µU/ml×min; p<0.05) and for GIP by 25% (7729±1548 vs. 6191±1049pmol/l×min; p<0.05). Glucose and GLP-1 responses were not affected by red wine. Wine consumption before an OGTT augments the insulin response, which may be partially driven by a greater GIP response. Because glucose levels were not reduced, acute wine consumption may not be effective treatment for enhancing glycemic control or may need to be combined with therapy that improves insulin sensitivity.